Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -2.38% 20.50 20.00 21.00 20.75 19.75 20.75 446,412 15:10:49
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.7 -0.3 - 13

Valirx Share Discussion Threads

Showing 24051 to 24074 of 24275 messages
Chat Pages: 971  970  969  968  967  966  965  964  963  962  961  960  Older
DateSubjectAuthorDiscuss
20/1/2021
12:12
No idea what the hell is going on here !!
amaretto1
20/1/2021
12:08
Getting ready for another top up
bobaxe1
20/1/2021
12:01
32 to 24 in a week. Laughable. Have we got anything commercial? Bought out for 2p soon. Pos
doerx2
20/1/2021
09:18
Looks like you have your chance!!
1savvyinvestor
19/1/2021
19:04
So annoying that I may have to add tomorrow
pennstreet
19/1/2021
15:23
I think personally it is all about getting all their ducks lined up first, so hopefully a deal may be in the wings for 201 or 301 or both!GLA
wulber
19/1/2021
11:00
Maybe the market was expecting a JV update on 291. No matter, it will come and then 30p will be history. GLA
tburns
19/1/2021
10:59
Doesn't look like it. Another price drop, very odd and annoying
cparry1989
19/1/2021
09:56
Mm's winding me up
bobaxe1
19/1/2021
09:55
Highest buy 29p yet graph shows 50p weirdly
bobaxe1
19/1/2021
09:36
Wait until they start trying to buy a few the opposite happens faster than the dips.
412069
19/1/2021
09:27
You coulnt make up this share price movement - madness
ragnarr
19/1/2021
08:37
Far too long, people will nibble at this now all the way to deal time imho.
412069
19/1/2021
08:31
'Should ' being the operative word!
pennstreet
19/1/2021
08:13
Great news should hit50 on that alone
bobaxe1
19/1/2021
08:09
19 January 2021... Will this Rns make any difference to the share price . ("ValiRx", the "Company" or the "Group") Patent Status Update Notification of allowance of VAL201 for the treatment of metastatic cancer and four other patents granted London, UK - ValiRx plc ("ValiRx", AIM:VAL), a clinical stage drug development company, announces that its patent portfolio continued to build in 2020, with four patents granted during the last 12 months (see table below). Additionally, in January 2021, the European Patent Office notified the Company of its intention to grant a patent which extends patent cover for VAL201 into metastatic cancer. These statements of protection are similar to those granted by the US patent office announced in November 2019 and creates a broad coverage of use of the peptide in an important area of oncology. The patents granted during 2020 and the notice received by the European Patent Office in relation to VAL201 can be found below: Project Patent Family Patent Granted Date Granted/allowance Impact VAL201 WO/2008/113770 JP6689430 April 2020 A new patent linked Use of the to the previously peptide against granted Japanese patents cancer to strengthen the portfolio ----------------- ---------------- ----------------------- -------------------------------- WO/2014/177868 EP number April 2021 Extends protection Use of the to be assigned for the use of VAL201 peptide against into metastatic cancer metastases ----------------- ---------------- ----------------------- -------------------------------- VAL301 WO/2013/064830 EP2773427 January 2021 This includes the Use of the use in the treatment peptide against of endometriosis, non-cancerous as well as other non-cancerous proliferative conditions hormone-driven conditions conditions (including hyperplasia) ----------------- ---------------- ----------------------- -------------------------------- VAL401 WO/2014/049071 CN104797271 March 2020 The first Chinese patent granted for VAL401, granted claims include the composition of the formulation and use in the treatment of cancerous and non-cancerous disease linked to the mechanism of action ----------------- ---------------- ----------------------- -------------------------------- JP6734346 August 2020 Covers the use of VAL401 in the treatment of lung cancer ----------------- ---------------- ----------------------- -------------------------------- The full patent portfolio for each project can be found on the project pages of the Company's website: hxxps://www.valirx.com/our-pipeline Dr Suzy Dilly, Chief Executive Officer commented: "It is important for ValiRx to continue to build value in our product portfolio by protecting intellectual property. The patenting process involves rigorous scrutiny of the proposal, testing for novelty and utility before a patent is allowed to be granted. Granted patents provide protection of the intellectual value of our research and provide further evidence to potential partners of the value of our products. "I am very pleased that we have continued to extend protection across our three core products through 2020 and into January of this year. This is an important component of value creation in the Company and a high priority for the Board." This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The Directors of the Company take responsibility for this announcement. Ends
thebossman
19/1/2021
08:06
Can we hold 30p this time.
412069
19/1/2021
07:38
https://twitter.com/aim_taking/status/1351432448312274945
412069
19/1/2021
07:05
RNS .... Good News !!
amaretto1
17/1/2021
18:50
This is :-)
amaretto1
17/1/2021
13:47
https://valneva.com/research-development/covid-19-vla2001/
rosco230667
17/1/2021
13:37
Maybe some investors watching the news today will have heard mention of Valneva VLA2001 Covid vaccine and assume it is Valirx. A buying rush pushing the price to £1 would enable me to jump ship. I can dream.
uknighted
17/1/2021
13:30
I was very pleased to see the share price close in positive territory on Friday, I didn't think it would, that instead there'd still be profit takers given the rise over the week. Im holding tightly to my shares...
lagansider
17/1/2021
10:48
I suspect a big week following the volume last week .
doc robinson
Chat Pages: 971  970  969  968  967  966  965  964  963  962  961  960  Older
ADVFN Advertorial
Your Recent History
LSE
VAL
Valirx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210308 22:50:10